We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




David Pall, Founder of Pall Corporation, Dies at 90.

By Labmedica staff writers
Posted on 07 Oct 2004
Dr. More...
David B. Pall, a chemist who founded the Pall Corporation in 1946 to commercialize his invention of a novel metallic filtration material, died on September 21, 2004, at his home in Roslyn Estates (NY, USA). He was 90.

David Boris Pall was born in Thunder Bay, Ontario (Canada) in April 1914, the son of Russian immigrants. He received his Ph.D. in physical chemistry from McGill University (Montreal) in 1939. After that, he moved to New York (NY, USA), where he worked as a research chemist on the Manhattan Project, a secret program resulting in the development of the atomic bomb.

In 1944, Dr. Pall began working in his garage on a metallic filter that would be able to handle heavy pressure, high temperatures, and corrosive materials. He invented many different kinds of filters and received 181 U.S. patents on his designs. Some designs were for filters used aboard airplanes or on helicopter engines. After his first wife, Josephine, died of plastic anemia, he invented filters for purifying blood used in transfusions that have made the procedure much safer by protecting transfused patients from viruses and other harmful pathogens.

Dr. Pall established a company called the Micro Metallic Corp. in East Hills, NY (USA) to distribute his new designs. The name was later changed to the Pall Corporation, which grew into a global company and a world leader in filtration under his tenure. In 1990, Dr. Pall was awarded the U.S. National Medal of Technology, the nation's highest honor in technology. Dr. Pall retired as chairman of Pall Corporation in 1992.

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.